- Quality Indicators for Bladder Cancer Services: A Collaborative Review. European Urology. 2019 Report GET IT
The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: A systematic review of the literature.
Times cited: 64
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: The SPARC trial.
Journal of Clinical Oncology.
Times cited: 248